Onyx Healthcare Inc. (TPEX:6569)
Taiwan
· Delayed Price · Currency is TWD 142.00
+1.50 (1.07%)
Apr 2, 2025, 1:30 PM CST
Onyx Healthcare Revenue
In the year 2024, Onyx Healthcare had annual revenue of 1.24B TWD, down -16.85%. Onyx Healthcare had revenue of 382.57M in the quarter ending December 31, 2024, a decrease of -12.01%.
Revenue
1.24B
Revenue Growth
-16.85%
P/S Ratio
4.41
Revenue / Employee
10.34M
Employees
120
Market Cap
5.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.24B | -251.61M | -16.85% |
| Dec 31, 2023 | 1.49B | -107.41M | -6.71% |
| Dec 31, 2022 | 1.60B | 398.51M | 33.16% |
| Dec 31, 2021 | 1.20B | -145.54M | -10.80% |
| Dec 31, 2020 | 1.35B | -135.64M | -9.15% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Caliway Biopharmaceuticals | 44.43M |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Center Laboratories | 1.62B |